Indole-3-Carbinol Eye Supplement Research: Blue Light, Retinas, and Broccoli

The Oasis Health Journal · Submitted August 17, 2026 · 6:01 PM EDT

By Tito Barragan · Edited by Nadine Cho

Indole-3-carbinol is what happens when you bite into broccoli and your spit does organic chemistry. Live. Without asking permission.

The precursor is glucobrassicin. The enzyme is myrosinase. They meet in your mouth, react, and produce I3C before you finish chewing. You are not eating indole-3-carbinol. You are making it between your molars like a tiny furious lab.

And according to three very different research teams studying three completely unrelated conditions, this molecule your mother told you to eat might be doing something interesting to cells under oxidative stress. Including, possibly, the ones in your retinas that spend all day staring at screens and wondering why they hurt. That is where the indole-3-carbinol eye supplement idea comes from: a compound with proven antioxidant pathways, meeting a tissue under constant light-induced oxidative assault, no referee.

The Trial That Was Not Looking For Vegetables

Researchers in China enrolled 252 patients with esophageal squamous cell carcinoma into a chemoimmunotherapy trial and drew their blood. A lot. Serial plasma samples across the entire treatment course, 541 draws total, looking for metabolic patterns that predicted who would respond and who would not.

They were not studying diet. They were not studying cruciferous vegetables. They were running an unbiased metabolomic screen, which is science-speak for "measure everything and see what shakes out."

Indole-3-carbinol shook out.

Patients whose plasma showed higher I3C levels, particularly early in treatment, had better outcomes. Not cured. Not saved. Better. The people eating cruciferous vegetable extracts or actual vegetables during chemo did measurably better than the ones who did not, and I3C was one of the metabolites that tracked with that difference.

The study did not give anyone I3C as an intervention. It just noticed it was there, in the blood of people whose immune cells were fighting a little harder. Correlation meet causation, you two should talk.

The Mouse Study That Measured Memory

Different year, different continent, different disease. Researchers bred APP/PS1 transgenic mice, which is the model you use when you want a mouse brain full of amyloid plaques and a publication deadline.

Then they gave some of the mice indole-3-carbinol.

I3C activates a receptor called AhR, the aryl hydrocarbon receptor, which sounds like something out of a hazmat manual but is actually a transcription factor your cells use all the time. When AhR wakes up, it walks into the nucleus and starts telling genes what to do. One of the things it tells them: make more neprilysin.

Neprilysin is an enzyme that degrades amyloid-beta, the protein that clumps into plaques in affected brains. More neprilysin, less plaque. The mice who got I3C performed better on memory tasks. The mice who got I3C plus an AhR inhibitor did not, which tells you the pathway matters and also that inhibiting the thing that helps is bad for mice.

This was in mice. Mice with artificially induced pathology. Nobody ran the trial in humans because humans are expensive and also litigious.

What This Has To Do With Your Eyes (Maybe)

Your retinas are under constant oxidative assault. Blue light from screens, overhead LEDs, the actual sun. High-energy visible light hits photoreceptors, generates reactive oxygen species, and your retinal cells spend all day mopping up the damage with antioxidant enzymes like the world's smallest janitorial staff.

The AhR pathway that I3C activates? It upregulates a bunch of those enzymes. Not just neprilysin. Also NQO1, GST, superoxide dismutase, the whole antioxidant defense system that keeps cells from oxidizing themselves to death.

Nobody has run a trial giving people an indole-3-carbinol eye supplement and measuring retinal enzyme activity before and after, because that would require a biopsy and a very brave volunteer with extremely poor decision-making skills. But the mechanism that worked in neurons and immune cells should, in theory, work in retinal pigment epithelium too.

Theory is cheap. Data costs grant money nobody has written yet.

The Kale Review Nobody Asked For

A 2021 review in Plants cataloged every phytochemical in kale that anyone had ever measured and reported that glucosinolates, the precursors to I3C, are one of the main bioactive families. Kale also contains carotenoids (lutein, zeaxanthin, the ones optometrists actually recommend for eyes), flavonoids, and a bunch of other compounds that may or may not do anything.

The review noted that stressing the plant while it is growing (heat, cold, drought, too much light) increases glucosinolate content. The kale that had a hard life probably has more of the compound you are after. This is useful if you are a farmer. If you are a supplement shopper, it means the cruciferous extract eye health capsule you are buying could contain anywhere from a little to a lot, depending on how mad the kale was when it got harvested.

Standardization is a word the supplement industry uses the way people use "I'll call you."

What The Studies Show, And What They Absolutely Do Not

The esophageal cancer trial showed that people whose plasma had more I3C did better on chemoimmunotherapy. It did not show that giving I3C to people without it would produce the same result, because nobody ran that experiment and also because cancer trials do not work that way.

The mouse study showed that I3C increased an enzyme that degrades amyloid and improved memory in a transgenic model. It did not show that I3C prevents cognitive decline in humans, because mice are not people and artificial plaques are not the same disease, no matter how many supplement ads forget this.

The kale review showed that cruciferous vegetables contain a lot of things, and I3C is one of them. It did not show that any of those things protect your retinas from blue light, because nobody measured that. They measured kale stress responses. Different column.

If you are looking for the best indole-3-carbinol supplement for eye support, the honest answer is: we do not know yet. The pathway is plausible. The molecule is real. The enzyme upregulation happens. Whether it happens in human retinal cells at the doses you would get from a capsule is a question that requires a trial nobody has funded, probably because broccoli is off-patent.

How To Get It, If You Want It Anyway

Eat broccoli. Kale. Cabbage. Brussels sprouts. Bok choy. Collards. Anything in the Brassica family that makes your tia say "ay, que saludable."

Chew it well, because the enzyme that converts glucobrassicin to I3C is in the plant cells and you have to break them open. Your molars are the lab equipment.

Cooking destroys some of the myrosinase, which is why raw or lightly steamed cruciferous vegetables give you more I3C than boiled mush. If you hate raw kale (claro, everybody does), steam it for three minutes and call it a day. If you boil it for twenty, you are makinghistamine soup for reasons only your abuela understands.

If you want a supplement, they exist. I3C blue light protection formulas are showing up on shelves next to lutein and zeaxanthin, sometimes combined, sometimes solo. Dosing in the studies that worked ranged from 200 to 400 milligrams per day, but those were cancer and neurological trials, not eye trials, so extrapolating is guesswork dressed up in a capsule.

One more thing: I3C breaks down into other compounds in your stomach, including diindolylmethane (DIM), which has its own research profile and its own supplement industry. Some people take DIM instead of I3C because it is more stable. Some people take both because more sounds better, which is the supplement equivalent of double-fisting energy drinks and wondering why their heart feels weird. Nobody knows which one works better for eyes because nobody has tested either one for eyes.

The Part Where We Say The Boring True Thing

This molecule does something. Probably several somethings. The receptor it activates is real, the enzymes it upregulates are real, and the effects measured in cancer patients and transgenic mice are not mirages or marketing.

But a mechanism is not a cure, and a plausible pathway is not a clinical result. If you are buying an indole-3-carbinol antioxidant supplement because you spend ten hours a day in front of a screen and your eyes hurt, you are making an educated guess based on incomplete data, same as the rest of us.

The vegetables are free. Well, not free. But cheaper than the capsules, and they come with fiber and the satisfaction of telling people you eat kale now.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Improving the Health-Benefits of Kales (Brassica oleracea L. var. acephala DC) through the Application of Controlled Abiotic Stresses: A Review, Plants (Basel, Switzerland) (2021).
2. Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin, Theranostics (2021).
3. Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy, Cancer discovery (2026).